| Code | Description | Claims | Beneficiaries | Total Paid |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
37,761 |
34,045 |
$4.90M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
34,460 |
31,746 |
$4.78M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,792 |
5,307 |
$4.41M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,415 |
13,489 |
$3.00M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,317 |
4,524 |
$1.39M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,525 |
4,123 |
$1.38M |
| G0378 |
Hospital observation service, per hour |
8,939 |
4,363 |
$1.02M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,950 |
1,827 |
$850K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
978 |
914 |
$728K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
11,651 |
7,591 |
$562K |
| 59025 |
Fetal non-stress test |
2,361 |
1,564 |
$504K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
975 |
919 |
$458K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
19,889 |
6,284 |
$407K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
408 |
328 |
$286K |
| 97162 |
|
3,099 |
2,978 |
$268K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,291 |
2,155 |
$254K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,020 |
984 |
$216K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,348 |
5,641 |
$179K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
820 |
739 |
$168K |
| 71046 |
Radiologic examination, chest; 2 views |
7,617 |
7,127 |
$159K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,287 |
2,239 |
$129K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,810 |
1,988 |
$112K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,572 |
1,496 |
$85K |
| 80053 |
Comprehensive metabolic panel |
27,997 |
21,683 |
$80K |
| 73562 |
|
1,915 |
1,837 |
$67K |
| 73130 |
|
1,741 |
1,667 |
$66K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
624 |
576 |
$62K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
390 |
374 |
$62K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,031 |
2,613 |
$62K |
| 73630 |
|
2,191 |
2,069 |
$57K |
| 93971 |
|
354 |
330 |
$56K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,080 |
1,042 |
$52K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
452 |
357 |
$47K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
562 |
253 |
$43K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,354 |
3,954 |
$39K |
| 73030 |
|
1,235 |
1,163 |
$37K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,646 |
9,082 |
$37K |
| 73610 |
|
1,592 |
1,503 |
$36K |
| 72110 |
|
287 |
282 |
$35K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
438 |
163 |
$34K |
| 97535 |
Self-care/home management training, each 15 minutes |
368 |
143 |
$34K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
54 |
50 |
$28K |
| 72100 |
|
275 |
265 |
$27K |
| 73110 |
|
1,174 |
1,106 |
$26K |
| 76801 |
|
97 |
88 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,748 |
1,872 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,516 |
6,437 |
$24K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
216 |
209 |
$23K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,205 |
8,022 |
$23K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
98 |
96 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
752 |
720 |
$22K |
| T1015 |
Clinic visit/encounter, all-inclusive |
156 |
63 |
$21K |
| 76642 |
|
426 |
408 |
$19K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
74 |
73 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
255 |
247 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
461 |
371 |
$15K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
642 |
218 |
$12K |
| 76830 |
Ultrasound, transvaginal |
757 |
729 |
$11K |
| 10060 |
|
134 |
130 |
$11K |
| 74018 |
|
248 |
220 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
108 |
106 |
$10K |
| 95811 |
|
14 |
13 |
$9K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,330 |
2,187 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,205 |
9,662 |
$8K |
| 73502 |
|
337 |
305 |
$7K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
53 |
53 |
$7K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,102 |
1,817 |
$7K |
| 73080 |
|
201 |
193 |
$6K |
| 86920 |
|
47 |
43 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
288 |
205 |
$6K |
| G0390 |
Trauma response team associated with hospital critical care service |
38 |
24 |
$6K |
| 71045 |
Radiologic examination, chest; single view |
7,304 |
6,454 |
$5K |
| 96376 |
|
4,223 |
2,428 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,748 |
23,316 |
$5K |
| 72131 |
|
12 |
12 |
$5K |
| 97161 |
|
209 |
182 |
$4K |
| 70486 |
|
55 |
52 |
$4K |
| 87510 |
|
1,924 |
1,717 |
$4K |
| 96367 |
|
1,938 |
1,477 |
$4K |
| 86850 |
|
1,853 |
1,671 |
$4K |
| 76775 |
|
55 |
49 |
$4K |
| 84702 |
|
414 |
348 |
$3K |
| C1788 |
Port, indwelling (implantable) |
43 |
39 |
$3K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,121 |
2,026 |
$3K |
| 80329 |
|
2,394 |
1,564 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
32 |
12 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,298 |
3,167 |
$2K |
| 72141 |
|
13 |
13 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
18 |
18 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
17,838 |
11,751 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
29 |
27 |
$2K |
| 94762 |
|
6,282 |
5,267 |
$2K |
| 87081 |
|
2,200 |
2,129 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
9,293 |
4,423 |
$2K |
| 73090 |
|
88 |
82 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
704 |
332 |
$2K |
| 72050 |
|
12 |
12 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,605 |
7,796 |
$2K |
| 77080 |
|
14 |
13 |
$2K |
| 87400 |
|
3,379 |
3,240 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,144 |
1,083 |
$1K |
| 87186 |
|
2,821 |
2,609 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
40,436 |
30,015 |
$1K |
| 87480 |
|
1,925 |
1,718 |
$1K |
| 71250 |
|
12 |
12 |
$1K |
| 83880 |
|
1,811 |
1,548 |
$1K |
| 87088 |
|
5,221 |
4,782 |
$904.19 |
| 81025 |
|
5,424 |
5,063 |
$868.38 |
| 12011 |
|
16 |
13 |
$866.23 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
25 |
25 |
$862.92 |
| 76857 |
|
17 |
17 |
$804.37 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
541 |
241 |
$773.55 |
| 85027 |
|
2,231 |
1,798 |
$773.36 |
| 80061 |
Lipid panel |
870 |
829 |
$760.42 |
| 76981 |
|
58 |
57 |
$741.66 |
| 87420 |
|
123 |
122 |
$714.66 |
| 82803 |
|
820 |
636 |
$701.20 |
| 73590 |
|
45 |
41 |
$494.12 |
| 82948 |
|
4,782 |
1,763 |
$448.78 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,245 |
1,200 |
$448.08 |
| 87653 |
|
12 |
12 |
$413.58 |
| 81003 |
|
19,582 |
16,867 |
$405.48 |
| 74019 |
|
17 |
12 |
$403.90 |
| 97802 |
|
13 |
13 |
$400.05 |
| 97803 |
|
12 |
12 |
$396.25 |
| 83735 |
|
3,526 |
2,236 |
$374.99 |
| 85610 |
|
4,542 |
3,899 |
$354.43 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,138 |
3,591 |
$311.34 |
| 84703 |
|
2,337 |
2,233 |
$306.06 |
| 82607 |
|
188 |
184 |
$278.92 |
| 84484 |
|
7,316 |
5,504 |
$275.81 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
93 |
84 |
$273.26 |
| 90715 |
|
871 |
845 |
$257.42 |
| 85730 |
|
3,438 |
3,016 |
$230.33 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
921 |
856 |
$227.45 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,825 |
1,742 |
$215.81 |
| 97116 |
|
104 |
50 |
$208.85 |
| 82728 |
|
82 |
82 |
$187.49 |
| 82962 |
|
1,455 |
779 |
$180.73 |
| 87040 |
|
2,998 |
1,761 |
$179.60 |
| 83690 |
|
5,087 |
4,459 |
$175.38 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,886 |
1,821 |
$175.01 |
| 84466 |
|
117 |
117 |
$173.75 |
| 90686 |
|
12 |
12 |
$170.64 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,470 |
8,359 |
$156.05 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
3,186 |
2,096 |
$155.38 |
| 87070 |
|
553 |
512 |
$148.14 |
| 87077 |
|
2,854 |
2,639 |
$130.33 |
| 88304 |
|
178 |
173 |
$103.43 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
217 |
208 |
$84.53 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
886 |
533 |
$83.20 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,770 |
6,838 |
$81.38 |
| 86900 |
|
2,103 |
1,893 |
$76.03 |
| J1815 |
Injection, insulin, per 5 units |
31 |
12 |
$66.99 |
| 85379 |
|
88 |
79 |
$61.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,400 |
2,379 |
$60.36 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
43 |
43 |
$58.67 |
| 86140 |
|
624 |
498 |
$52.34 |
| 83605 |
|
3,332 |
2,620 |
$47.46 |
| 82746 |
|
43 |
42 |
$45.88 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,198 |
4,229 |
$43.71 |
| 86592 |
|
126 |
125 |
$38.02 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,237 |
2,577 |
$33.69 |
| 82043 |
|
102 |
100 |
$30.44 |
| 87660 |
|
1,925 |
1,718 |
$28.34 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,491 |
1,226 |
$21.33 |
| 85652 |
|
579 |
509 |
$20.74 |
| 82550 |
|
868 |
740 |
$19.36 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,432 |
1,241 |
$17.84 |
| 80320 |
|
2,697 |
2,447 |
$17.04 |
| 82248 |
|
18 |
16 |
$14.34 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
371 |
219 |
$10.00 |
| 84100 |
|
44 |
31 |
$8.56 |
| 82272 |
|
13 |
12 |
$7.33 |
| 86901 |
|
2,103 |
1,893 |
$5.48 |
| 84156 |
|
42 |
38 |
$4.04 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,333 |
1,152 |
$3.24 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,546 |
3,849 |
$0.99 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
315 |
262 |
$0.03 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,019 |
2,657 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,235 |
2,189 |
$0.00 |
| 94760 |
|
1,392 |
743 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,300 |
1,218 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,334 |
1,762 |
$0.00 |
| 99156 |
|
315 |
299 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
351 |
263 |
$0.00 |
| J3490 |
Unclassified drugs |
1,243 |
1,098 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
675 |
356 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
1,963 |
1,319 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
49 |
49 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,712 |
1,502 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
90 |
83 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
772 |
738 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
627 |
479 |
$0.00 |
| 88342 |
|
278 |
261 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
23 |
12 |
$0.00 |
| 12001 |
|
164 |
152 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
60 |
53 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
201 |
107 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
586 |
313 |
$0.00 |
| 91301 |
|
12 |
12 |
$0.00 |
| 83615 |
|
65 |
58 |
$0.00 |
| 87340 |
|
67 |
67 |
$0.00 |
| 88341 |
|
30 |
25 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
26 |
25 |
$0.00 |
| 97014 |
|
72 |
41 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
18 |
14 |
$0.00 |
| 86762 |
|
13 |
13 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
16 |
14 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
13 |
13 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
400 |
283 |
$0.00 |
| 84145 |
|
26 |
24 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
341 |
239 |
$0.00 |
| 0502F |
|
1,115 |
885 |
$0.00 |
| 84439 |
|
532 |
513 |
$0.00 |
| 83540 |
|
132 |
132 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
339 |
148 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
267 |
168 |
$0.00 |
| 86787 |
|
25 |
25 |
$0.00 |
| 84460 |
|
17 |
15 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
158 |
80 |
$0.00 |
| 82570 |
|
259 |
240 |
$0.00 |
| 82010 |
|
15 |
13 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
41 |
25 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
387 |
352 |
$0.00 |
| 85007 |
|
14 |
13 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
115 |
43 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
15 |
$0.00 |
| 94664 |
|
16 |
12 |
$0.00 |
| 82140 |
|
16 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
17 |
16 |
$0.00 |